Europe Antiandrogen Market Research Report Forecast 2017-2022

July 2017 | 118 pages | ID: ED47A226E18EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Antiandrogen Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Antiandrogen industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Antiandrogen market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Antiandrogen Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Pfizer
Abbott Laboratories
Genentech
GlaxoSmithKline
Immunomedics
Indevus Pharmaceuticals
Novartis AG
company 8
company 9

Europe Antiandrogen Market Analysis by Product:

• Type 1
• Type 2
• Type 3

Europe Antiandrogen Market Analysis by Application:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 ANTIANDROGEN MARKET OVERVIEW

1.1 Product Overview and Scope of Antiandrogen
1.2 Classification of Antiandrogen
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Antiandrogen
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Antiandrogen Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Antiandrogen (2012-2022)
  1.5.1 Europe Antiandrogen Sales and Growth Rate (2012-2022)
  1.5.2 Europe Antiandrogen Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON ANTIANDROGEN INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 ANTIANDROGEN MANUFACTURING COST ANALYSIS

3.1 Antiandrogen Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Antiandrogen

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Antiandrogen Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Antiandrogen Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE ANTIANDROGEN MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Antiandrogen Market Competition by Manufacturers
  5.1.1 Europe Antiandrogen Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Antiandrogen Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Antiandrogen (Volume and Value) by Type
  5.2.1 Europe Antiandrogen Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Antiandrogen Revenue and Market Share by Type (2012-2017)
5.3 Europe Antiandrogen (Volume and Value) by Countries
  5.3.1 Europe Antiandrogen Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Antiandrogen Revenue and Market Share by Countries (2012-2017)
5.4 Europe Antiandrogen (Volume) by Application

6 GERMANY ANTIANDROGEN (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Antiandrogen Sales and Value (2012-2017)
  6.1.1 Germany Antiandrogen Sales and Growth Rate (2012-2017)
  6.1.2 Germany Antiandrogen Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Antiandrogen Sales Price Trend (2012-2017)
6.2 Germany Antiandrogen Sales and Market Share by Manufacturers
6.3 Germany Antiandrogen Sales and Market Share by Type
6.4 Germany Antiandrogen Sales and Market Share by Application

7 FRANCE ANTIANDROGEN (VOLUME, VALUE AND SALES PRICE)

7.1 France Antiandrogen Sales and Value (2012-2017)
  7.1.1 France Antiandrogen Sales and Growth Rate (2012-2017)
  7.1.2 France Antiandrogen Revenue and Growth Rate (2012-2017)
  7.1.3 France Antiandrogen Sales Price Trend (2012-2017)
7.2 France Antiandrogen Sales and Market Share by Manufacturers
7.3 France Antiandrogen Sales and Market Share by Type
7.4 France Antiandrogen Sales and Market Share by Application

8 UK ANTIANDROGEN (VOLUME, VALUE AND SALES PRICE)

8.1 UK Antiandrogen Sales and Value (2012-2017)
  8.1.1 UK Antiandrogen Sales and Growth Rate (2012-2017)
  8.1.2 UK Antiandrogen Revenue and Growth Rate (2012-2017)
  8.1.3 UK Antiandrogen Sales Price Trend (2012-2017)
8.2 UK Antiandrogen Sales and Market Share by Manufacturers
8.3 UK Antiandrogen Sales and Market Share by Type
8.4 UK Antiandrogen Sales and Market Share by Application

9 RUSSIA ANTIANDROGEN (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Antiandrogen Sales and Value (2012-2017)
  9.1.1 Russia Antiandrogen Sales and Growth Rate (2012-2017)
  9.1.2 Russia Antiandrogen Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Antiandrogen Sales Price Trend (2012-2017)
9.2 Russia Antiandrogen Sales and Market Share by Manufacturers
9.3 Russia Antiandrogen Sales and Market Share by Type
9.4 Russia Antiandrogen Sales and Market Share by Application

10 ITALY ANTIANDROGEN (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Antiandrogen Sales and Value (2012-2017)
  10.1.1 Italy Antiandrogen Sales and Growth Rate (2012-2017)
  10.1.2 Italy Antiandrogen Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Antiandrogen Sales Price Trend (2012-2017)
10.2 Italy Antiandrogen Sales and Market Share by Manufacturers
10.3 Italy Antiandrogen Sales and Market Share by Type
10.4 Italy Antiandrogen Sales and Market Share by Application

11 SPAIN ANTIANDROGEN (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Antiandrogen Sales and Value (2012-2017)
  11.1.1 Spain Antiandrogen Sales and Growth Rate (2012-2017)
  11.1.2 Spain Antiandrogen Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Antiandrogen Sales Price Trend (2012-2017)
11.2 Spain Antiandrogen Sales and Market Share by Manufacturers
11.3 Spain Antiandrogen Sales and Market Share by Type
11.4 Spain Antiandrogen Sales and Market Share by Application

12 BENELUX ANTIANDROGEN (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Antiandrogen Sales and Value (2012-2017)
  12.1.1 Benelux Antiandrogen Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Antiandrogen Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Antiandrogen Sales Price Trend (2012-2017)
12.2 Benelux Antiandrogen Sales and Market Share by Manufacturers
12.3 Benelux Antiandrogen Sales and Market Share by Type
12.4 Benelux Antiandrogen Sales and Market Share by Application

13 EUROPE ANTIANDROGEN MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Abbott Laboratories
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Genentech
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 GlaxoSmithKline
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Immunomedics
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Indevus Pharmaceuticals
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Novartis AG
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 company
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 company
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE ANTIANDROGEN MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Antiandrogen Market Forecast by Type (2017-2022)
15.9 Europe Antiandrogen Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antiandrogen
Table Classification of Antiandrogen
Figure Europe Sales Market Share of Antiandrogen by Type in 2016
Table Application of Antiandrogen
Figure Europe Sales Market Share of Antiandrogen by Application in 2016
Figure Germany Antiandrogen Revenue and Growth Rate (2012-2022)
Figure France Antiandrogen Revenue and Growth Rate (2012-2022)
Figure UK Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Russia Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Italy Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Spain Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Benelux Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Europe Antiandrogen Sales and Growth Rate (2012-2022)
Figure Europe Antiandrogen Revenue and Growth Rate (2012-2022)
Table Europe Antiandrogen Sales of Key Manufacturers (2015 and 2016)
Table Europe Antiandrogen Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Sales Share by Manufacturers
Figure 2016 Antiandrogen Sales Share by Manufacturers
Table Europe Antiandrogen Revenue by Manufacturers (2015 and 2016)
Table Europe Antiandrogen Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antiandrogen Revenue Share by Manufacturers
Table 2016 Europe Antiandrogen Revenue Share by Manufacturers
Table Europe Antiandrogen Sales and Market Share by Type (2012-2017)
Table Europe Antiandrogen Sales Share by Type (2012-2017)
Figure Sales Market Share of Antiandrogen by Type (2012-2017)
Figure Europe Antiandrogen Sales Growth Rate by Type (2012-2017)
Table Europe Antiandrogen Revenue and Market Share by Type (2012-2017)
Table Europe Antiandrogen Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antiandrogen by Type (2012-2017)
Figure Europe Antiandrogen Revenue Growth Rate by Type (2012-2017)
Table Europe Antiandrogen Sales and Market Share by Countries (2012-2017)
Table Europe Antiandrogen Sales Share by Countries (2012-2017)
Figure Sales Market Share of Antiandrogen by Countries (2012-2017)
Table Europe Antiandrogen Revenue and Market Share by Countries (2012-2017)
Table Europe Antiandrogen Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Antiandrogen by Countries (2012-2017)
Table Europe Antiandrogen Sales and Market Share by Application (2012-2017)
Table Europe Antiandrogen Sales Share by Application (2012-2017)
Figure Sales Market Share of Antiandrogen by Application (2012-2017)
Figure Germany Antiandrogen Sales and Growth Rate (2012-2017)
Figure Germany Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Germany Antiandrogen Sales Price Trend (2012-2017)
Table Germany Antiandrogen Sales by Manufacturers (2015 and 2016)
Table Germany Antiandrogen Market Share by Manufacturers (2015 and 2016)
Table Germany Antiandrogen Sales by Type (2015 and 2016)
Table Germany Antiandrogen Market Share by Type (2015 and 2016)
Table Germany Antiandrogen Sales by Application (2015 and 2016)
Table Germany Antiandrogen Market Share by Application (2015 and 2016)
Figure France Antiandrogen Sales and Growth Rate (2012-2017)
Figure France Antiandrogen Revenue and Growth Rate (2012-2017)
Figure France Antiandrogen Sales Price Trend (2012-2017)
Table France Antiandrogen Sales by Manufacturers (2015 and 2016)
Table France Antiandrogen Market Share by Manufacturers (2015 and 2016)
Table France Antiandrogen Sales by Type (2015 and 2016)
Table France Antiandrogen Market Share by Type (2015 and 2016)
Table France Antiandrogen Sales by Application (2015 and 2016)
Table France Antiandrogen Market Share by Application (2015 and 2016)
Figure UK Antiandrogen Sales and Growth Rate (2012-2017)
Figure UK Antiandrogen Revenue and Growth Rate (2012-2017)
Figure UK Antiandrogen Sales Price Trend (2012-2017)
Table UK Antiandrogen Sales by Manufacturers (2015 and 2016)
Table UK Antiandrogen Market Share by Manufacturers (2015 and 2016)
Table UK Antiandrogen Sales by Type (2015 and 2016)
Table UK Antiandrogen Market Share by Type (2015 and 2016)
Table UK Antiandrogen Sales by Application (2015 and 2016)
Table UK Antiandrogen Market Share by Application (2015 and 2016)
Figure Russia Antiandrogen Sales and Growth Rate (2012-2017)
Figure Russia Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Russia Antiandrogen Sales Price Trend (2012-2017)
Table Russia Antiandrogen Sales by Manufacturers (2015 and 2016)
Table Russia Antiandrogen Market Share by Manufacturers (2015 and 2016)
Table Russia Antiandrogen Sales by Type (2015 and 2016)
Table Russia Antiandrogen Market Share by Type (2015 and 2016)
Table Russia Antiandrogen Sales by Application (2015 and 2016)
Table Russia Antiandrogen Market Share by Application (2015 and 2016)
Figure Italy Antiandrogen Sales and Growth Rate (2012-2017)
Figure Italy Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Italy Antiandrogen Sales Price Trend (2012-2017)
Table Italy Antiandrogen Sales by Manufacturers (2015 and 2016)
Table Italy Antiandrogen Market Share by Manufacturers (2015 and 2016)
Table Italy Antiandrogen Sales by Type (2015 and 2016)
Table Italy Antiandrogen Market Share by Type (2015 and 2016)
Table Italy Antiandrogen Sales by Application (2015 and 2016)
Table Italy Antiandrogen Market Share by Application (2015 and 2016)
Figure Spain Antiandrogen Sales and Growth Rate (2012-2017)
Figure Spain Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Spain Antiandrogen Sales Price Trend (2012-2017)
Table Spain Antiandrogen Sales by Manufacturers (2015 and 2016)
Table Spain Antiandrogen Market Share by Manufacturers (2015 and 2016)
Table Spain Antiandrogen Sales by Type (2015 and 2016)
Table Spain Antiandrogen Market Share by Type (2015 and 2016)
Table Spain Antiandrogen Sales by Application (2015 and 2016)
Table Spain Antiandrogen Market Share by Application (2015 and 2016)
Figure Benelux Antiandrogen Sales and Growth Rate (2012-2017)
Figure Benelux Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Benelux Antiandrogen Sales Price Trend (2012-2017)
Table Benelux Antiandrogen Sales by Manufacturers (2015 and 2016)
Table Benelux Antiandrogen Market Share by Manufacturers (2015 and 2016)
Table Benelux Antiandrogen Sales by Type (2015 and 2016)
Table Benelux Antiandrogen Market Share by Type (2015 and 2016)
Table Benelux Antiandrogen Sales by Application (2015 and 2016)
Table Benelux Antiandrogen Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Antiandrogen Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Antiandrogen Sales Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Antiandrogen Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Antiandrogen Sales Market Share (2012-2017)
Table Immunomedics Basic Information List
Table Immunomedics Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics Antiandrogen Sales Market Share (2012-2017)
Table Indevus Pharmaceuticals Basic Information List
Table Indevus Pharmaceuticals Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Antiandrogen Sales Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Antiandrogen Sales Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Antiandrogen Sales Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Antiandrogen Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen
Figure Manufacturing Process Analysis of Antiandrogen
Figure Antiandrogen Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Major Manufacturers in 2016
Table Major Buyers of Antiandrogen
Table Distributors/Traders List
Figure Germany Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure Germany Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Figure France Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure France Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Figure UK Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure UK Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure Russia Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure Italy Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure Spain Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Table Europe Antiandrogen Sales Forecast by Type (2017-2022)
Table Europe Antiandrogen Sales Forecast by Application (2017-2022)